Chinook Therapeutics Inc Cvr (ADRO)

Deferred Revenue

$3.79M

Quarterly · Period ending: · USD

ADRO logo

ADRO Deferred Revenue

Latest reported$6.95M
ADRO FY Deferred Revenue ($57.00K → $6.95M)
High-resolution chart · PNG

ADRO deferred revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Chinook Therapeutics Inc Cvr Deferred Revenue — Annual fiscal periods (USD)
Period endingDeferred Revenue (USD)
6,950,000
16,000,000
14,923,000
15,052,000
15,046,000
33,427,000
57,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.